Home › Conditions › Acute Heart Failure / Pulmonary Oedema
Cardiology
Acute Heart Failure / Pulmonary Oedema
Acute HF presents with breathlessness, orthopnoea, fine crepitations, and sometimes frothy sputum. Classify by haemodynamic profile: warm & wet (most common — diurese), cold & wet (cardiogenic shock — cautious diuresis, consider inotropes), warm & dry (euvolaemic). The mnemonic LMNOP guides initial management.
LMNOP / AHF Protocol
The pathway
A-E & diagnosis
SpO₂, RR, HR, BP, JVP, peripheral oedema, lung auscultation. Sitting upright. 12-lead ECG, CXR (bat-wing oedema, Kerley B lines, cardiomegaly). BNP/NT-proBNP, troponin, U&E, FBC.
LMNOP mnemonic
- L-Lasix: furosemide 40–80mg IV, adjusted to prior dose/congestion
- M-Morphine: not routine; selected severe pain or palliation
- N-Nitrates: consider GTN for severe hypertension/ischaemia; monitor BP, IV use in level 2 care (ESC: SBP>110)
- O-Oxygen: target 94–98%, or 88–92% if hypercapnia risk
- P-Position: sit upright
CPAP consideration
- Severe distress (RR >25, SpO₂ <90%) or acidaemia: start CPAP at 5 cmH₂O, titrate to 10; monitor BP and ABG
- Improves oxygenation and work of breathing
- Vomiting, falling GCS, exhaustion or unstable BP → anaesthetics/ICU
Furosemide dosing
- Diuretic-naïve: furosemide 40mg IV is a usual start
- Already taking a loop: consider 2× usual total daily oral dose IV, adjusted for congestion/BP/renal function
- Give slowly; higher doses by infusion (usually ≤4mg/min, check product)
- Monitor hourly UO, fluid balance and U&E; poor response → reassess and discuss escalation with HF/critical-care team
Precipitant identification
Find and treat the cause: ACS (troponin/ECG), AF (rate/rhythm control), hypertensive emergency (IV antihypertensives), infection (antibiotics), medication non-compliance (patient history), fluid overload (dietary salt).
Escalation thresholds
- Hypotension + hypoperfusion: stop nitrates; call ICU/cardiology now
- Reassess filling/ congestion before further diuresis; consider noradrenaline ± dobutamine with ICU
- Respiratory failure worsening despite CPAP: anaesthetics for intubation assessment
- Suspected acute coronary occlusion/STEMI: urgent PCI pathway; other new wall-motion changes need urgent cardiology assessment
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Furosemide | 40–80mg | Slow IV injection/infusion | 40mg is a usual diuretic-naïve start. If already taking a loop, consider 2× total daily oral dose IV. Higher doses by slow infusion; monitor BP, UO and U&E before escalation. |
| GTN spray | 400–800mcg (1–2 sprays) | Sublingual | 400mcg per spray; two sprays=800mcg. For selected hypertensive/ischaemic patients; monitor BP, avoid hypotension. Repeat every 5 min if appropriate; IV infusion needs monitored care, not routine use. |
| Morphine | Not routinely recommended | IV slow | Not routine in acute heart failure — associated with more ventilation and ITU admission. Reserve for distressing pain or palliative breathlessness, small dose, watching for respiratory depression. |
| CPAP | 5–10 cmH2O | Non-invasive | Severe dyspnoea/acidaemia: start promptly at 5 cmH₂O, titrate to 10. Monitor BP, ABG, airway protection and response. |
When to escalate
- SBP <90 after initial treatment → cardiogenic shock protocol, ITU
- Worsening on CPAP (SpO₂ <90%, tiring, falling GCS) → anaesthetics/ICU.
- New STEMI → primary PCI pathway; rising troponin or new wall-motion abnormality → urgent clinical/ECG review and cardiology
- No urine output after IV furosemide → AKI, nephrology input
- AF with haemodynamic compromise → DC cardioversion
Reference: ESC Acute Heart Failure Guidelines 2021 / NICE CG187 Acute Heart Failure
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.